Trials / Completed
CompletedNCT04382287
Comparison of Remineralisation Efficacy of MI PASTE Plus® and REMIN PRO® for White Spot Lesions in Primary Teeth
Comparison of Clinical Efficacy of MI PASTE Plus® and REMIN PRO® for the Remineralisation of Enamel White Spot Lesions in Primary Teeth
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Universidad Autonoma de San Luis Potosí · Academic / Other
- Sex
- All
- Age
- 2 Years – 5 Years
- Healthy volunteers
- Accepted
Summary
The present study aimed to compare the remineralisation capacity of white spot enamel lesions between two commercially available tooth pastes (Remin Pro and MI PASTE PLUS), applied at home twice a day on the anterior upper primary teeth by the patient and parents.
Detailed description
Objective: To evaluate and compare the clinical efficacy of Remin Pro® and MI Paste Plus® for the remineralisation of white spot lesions (WSL) on the enamel of primary teeth. Methods: The selected design for this study was a randomised double-blind clinical trial based on CONSORT guidelines. Patients with at least one upper anterior primary tooth with a WSL on the enamel surface, with units of fluorescence (UF) ranged from 11-20 (evaluated with DIAGNOdent) were included in the study. Patients were randomly assigned to receive either the twice-daily at-home topical application of Remin Pro® or MI Paste Plus® (both as experimental pastes) or Colgate Total® (as control paste). The degree of remineralisation was quantified by the change in the number of UF from the baseline evaluation and at days 10 and 21. The difference between groups was statistically evaluated using ANCOVA and ANOVA techniques.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Remin Pro® and MI Paste Plus® | Te toothastes were applied at home twice a day over the six anterior upper primary teeth |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-09-09
- Completion
- 2019-11-20
- First posted
- 2020-05-11
- Last updated
- 2020-05-11
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04382287. Inclusion in this directory is not an endorsement.